Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
about
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
@ast
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
@en
type
label
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
@ast
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
@en
prefLabel
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
@ast
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
@en
P2093
P2860
P356
P1476
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
@en
P2093
Angel A Isidro
Beatriz Pagán
Caroline B Appleyard
Domenico Coppola
Myrella L Cruz
P2860
P304
P356
10.3748/WJG.V17.I44.4858
P407
P577
2011-11-01T00:00:00Z